Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Breast Neoplasms 243Neoplasms 17Neoplasm Metastasis 15Carcinoma, Intraductal, Noninfiltrating 11Breast Diseases 8Advanced Breast Cancer 8Breast Neoplasms, Male 7Breast Carcinoma In Situ 7Triple Negative Breast Neoplasms 5Ovarian Neoplasms 5Endometrial Neoplasms 5Arthralgia 5Neoplasms by Site 3Breast Cancer Metastatic 3Uterine Cervical Neoplasms 2Recurrence 2Patient Compliance 2Osteoporosis 2Obesity 2Multiple Endocrine Neoplasia Type 1 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasm Female 2Vitamin D Deficiency 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Seizures 1Sarcoma 1

Interventions

testosterone undecanoate 4Testosterone 3Alendronate 2testosterone 17 beta-cypionate 1Triptorelin Pamoate 1Testosterone Propionate 1Tamoxifen 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Pioglitazone 1Orchiectomy 1Observation 1Methyltestosterone 1Mental Status and Dementia Tests 1Gonadotropin-Releasing Hormone 1Gels 1Drug Evaluation 1Clomiphene 1Castor Oil 1Blood Specimen Collection 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypogonadism × Anastrozole × Clear all
NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed
40 enrolled 13 charts
EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡